论文部分内容阅读
目的分析百色市耐药结核病筛查工作现况,为今后科学防控提供依据。方法对2012年1月~2016年9月全市耐药结核病的筛查数据进行分析,评价本地区耐药结核病的感染状况,以全市各县(区)耐药结核病筛查机构建设的完善程度评价本地区耐药结核病筛查工作的扎实程度,以“五类高危人群”筛查情况评价耐药结核病筛查工作的质量。结果全市共完成了1 468例结核病人的耐药筛查工作,但在国家结核病专报系统上显示的“五类高危人群”中仅完成了62.91%(268/426),耐多药/广泛耐药结核筛出率为4.81%(32/665),总耐药率达到13.98%(93/665),形势严峻;而目前能独立完成结核病人痰培养的县(区)仅有41.67%(5/12),委托市级机构帮开展痰培养的有50.00%(6/12),尚有一个县没有开展任何工作,这也是造成筛查面不够深入的原因,同时筛查出来之后的病人治疗管理工作难度很大。结论一是要继续重视结核病人的归口管理和提高DOTS策略的质量,严防耐药结核病的蔓延;二是加大基层机构的建设力度,健全耐药结核的监测网;三是加大投入,完成筛查出来的耐药结核病人治疗工作。
Objective To analyze the status of drug-resistant TB screening in Baise City and provide the basis for future scientific prevention and control. Methods The screening data of drug-resistant TB in the city from January 2012 to September 2016 were analyzed to evaluate the infection status of drug-resistant TB in the region. Based on the evaluation of the perfection of the construction of drug-resistant TB screening institutions in counties (districts) The level of drug-resistant TB screening work in the region is solid, and the quality of drug-resistant TB screening is evaluated based on the screening of “five categories of high-risk groups.” Results A total of 1 468 cases of TB drug resistance screening were completed in the city. However, only 62.91% (268/426) of the “five types of high-risk groups” showed in the national TB system showed that MDR / The rate of extensive drug-resistant tuberculosis screening was 4.81% (32/665), the total drug resistance rate reached 13.98% (93/665), the situation is grim; while the county (district) that can independently complete the sputum culture of TB patients is only 41.67 % (5/12), commissioned municipal agencies to carry out sputum culture of 50.00% (6/12), there is a county did not do any work, which is caused by the screening is not deep enough reason, at the same time screening out Patient treatment management is very difficult. The first is to continue to attach importance to the centralized management of tuberculosis patients and improve the quality of DOTS strategy to prevent the spread of drug-resistant TB; second is to increase the building of grass-roots institutions, improve the monitoring network of drug-resistant TB; third is to increase investment and complete Screening of drug-resistant TB patients for treatment.